Grants (medicine, biopharmaceutical research | worldwide)

Listed on GrantGunner. Last checked 14 Nov 2026.

About this grant

The Grants from the biopharmaceutical company Alnylam support organizations worldwide in projects that enable the advancement of patient care, focusing on Transthyretin-mediated Amyloidosis, Acute Hepatic Porphyria, and Primary Hyperoxaluria Type 1. Alnylam supports unsolicited requests for Continuing Medical Education Grants (CME), Educational Grants (non-CME), and Fellowships. Applications may be submitted at any time, but must be sent at least 45 days prior to the activity start date.

Browse all open grants

More grants from Alnylam Pharmaceuticals